| Literature DB >> 36079729 |
Macarena Torrego-Ellacuría1, Ana Barabash1,2,3, Pilar Matía-Martín1,2, Andrés Sánchez-Pernaute2,4, Antonio J Torres2,4, Alfonso L Calle-Pascual1,2,3, Miguel A Rubio-Herrera1,2.
Abstract
The Circadian Locomotor Output Cycles Kaput (CLOCK) gene has been linked to metabolic dysfunction and obesity. The purpose of this study was to analyze the association between single nucleotide polymorphisms (SNPs) of CLOCK gene with obesity and with long-term weight response after different bariatric surgery (BS) techniques. The cohort includes 375 patients with morbid obesity (MO) and 230 controls. In the association study of SNPs with weight response we combined several variables as phenotype at 6 years after surgery. The study protocol was registered in ISRCTN (ID80961259). The analysis of the selected SNPs was performed by allelic discrimination using Taqman® probes. The genotype association study was performed using the SNPStats program, with comparisons adjusted for sex, age, initial Body Mass Index, type 2 diabetes and hypertension diagnosis, and type of surgery. In the case-control study two of three SNPs were significantly associated with MO. The variant rs1801260 had a protective effect for MO whereas the TT genotype of rs3749474 variant had the strongest association with MO (OR = 2.25 (1.39-3.66); p = 0.0006). In the linear regression analysis both variants showed significant association with long-term weight loss and weight regain after BS, independently of the pre-surgery patient profile.Entities:
Keywords: CLOCK gene; SNP; bariatric surgery; obesity; weight regain
Mesh:
Substances:
Year: 2022 PMID: 36079729 PMCID: PMC9460349 DOI: 10.3390/nu14173472
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Absolute and relative frequency of genotypes of the included CLOCK gene variants.
| SNP | Genotype | Controls n (%) | Cases n (%) |
|---|---|---|---|
| rs3749474 | C/C * | 100 (44.2%) | 142 (37.9%) |
| C/T | 101 (44.7%) | 152 (40.5%) | |
| T/T | 25 (11.1%) | 81 (21.6%) | |
| rs1801260 | A/A * | 115 (50.2%) | 202 (53.9%) |
| A/G | 90 (39.3%) | 157 (41.9%) | |
| G/G | 24 (10.5%) | 16 (4.3%) | |
| rs4580704 | G/G * | 30 (13.1%) | 52 (13.9%) |
| G/C | 105 (45.9%) | 169 (45.1%) | |
| C/C | 94 (41%) | 154 (41.1%) |
* Reference genotype. SNP, single nucleotide polymorphism.
Profile of cases included in the genetic study (N = 375).
| Variable | Value |
|---|---|
| Age, in years | 44.79 ± 11.99 |
| BMI_00, kg/m2 | 44.87 ± 6.59 |
| Female gender, n (%) | 259 (69) |
| T2D, n (%) | 134 (35.7) |
| HTN, n (%) | 182 (49) |
| %TWL_nadir, | 38.79 ± 9.84 |
| %EWL_nadir, | 91.19 ± 23.69 |
| %TWL_6y | 31.67 ± 11.62 |
| %EWL_6y | 74.08 ± 26.89 |
| %EWL > 50%, n (%) | 311 (82.93) |
| %TWL > 20%, n (%) | 317 (84.53) |
| %WR_MWL, median (IQR) | 15.76 (7.99–28.69) |
Mean (SD) unless otherwise stated. BMI_00, presurgery body mass index; T2D, type 2 diabetes; HTN, hypertension; TWL, total weight loss; EWL, excess weight loss; WR_MWL, weight regain from the maximum weight loss.
Figure 1Mean %TWL in the follow up by rs1801260 genotypes.
Figure 2Mean %TWL in the follow up by rs3749474 genotypes.
Mean values of weight response variables by genotypes. Global cohort (N = 375).
| SNP | Genotype | n | %TWL_nadir | %TWL_6y | %WR_MWL |
|---|---|---|---|---|---|
| rs3749474 | C/C | 142 | 39.48 ± 0.86 | 32.26 ± 0.97 | 20.04 ± 1.55 |
| C/T | 152 | 38.11 ± 0.78 | 31.45 ± 0.93 | 19.24 ± 1.31 | |
| T/T | 81 | 38.84 ± 1.07 | 31.03 ± 1.35 | 22.35 ± 2.41 | |
| rs1801260 | A/A/ | 202 | 38.87 ± 0.67 | 31.22 ± 0.83 | 21.63 ± 1.36 |
| A/G | 157 | 38.31 ± 0.82 | 31.73 ± 0.9 | 18.95 ± 1.37 | |
| G/G | 16 | 42.43 ± 2.31 | 36.7 ± 2.97 | 14.88 ± 3.61 | |
| rs4580704 | G/G | 52 | 39.09 ± 1.22 | 30.65 ± 1.5 | 20.39 ± 1.5 |
| G/C | 169 | 39.48 ± 0.8 | 32.56 ± 0.9 | 19.29 ± 1.43 | |
| C/C | 154 | 37.93 ± 0.77 | 31.03 ± 0.95 | 22.73 ± 2.32 |
TWL, total weight loss; WR_MWL, weight regain from the maximum weight loss. Results adjusted by age, sex, T2D, HTN, type of surgical technique, and initial BMI.
Figure 3Association of rs3749474 genotypes with WR at year 6 in the malabsorptive cohort.